Evidence map›Paper›PMID 40932342›Full record

ArticleInternational journal of surgery (London, England)2026

Fully end-to-end automated bladder segmentation and risk assessment based on bladder morphology features for predicting upper urinary tract dysfunction.

Zhonghan Zhou, Tianyang Hang, Juan Wu, Tianyu Xiang, Ping Zhong, Xin Liu, Gongyue Liu, Junjie Ji, Yixi Liu, Limin Liao

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhonghan ZhouDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Tianyang HangSchool of Big Data, Taishan College of Science and Technology, Tai'an, Shandong, China.
Juan WuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Tianyu XiangDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Ping ZhongDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Xin LiuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Gongyue LiuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Junjie JiDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Yixi LiuDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.
Limin LiaoDepartment of Urology, China Rehabilitation Research Center, School of Rehabilitation of Capital Medical University, Beijing, China.ORCID 0009-0007-0369-9725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aims to analyze bladder morphology features for upper urinary tract dysfunction (UUTD) risk assessment and develop a fully end-to-end (E2E) automated segmentation and risk identification algorithm. MATERIALS AND

methodsA retrospective cohort of 604 neurogenic bladder patients undergoing video-urodynamics was analyzed. Bladder regions of interest (ROIs) were manually and automatically segmented. Thirty-six morphology features, including shape, Laplacian of Gaussian histograms, and fractal characteristics, were extracted from ROIs. After LASSO regression, selected predictive features were integrated into machine learning models. Model performance was evaluated via the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis.

resultsBased on manually segmented ROI, 28 (77.78%) morphology features exhibited significant differences between different bladder grades. Shape_Perimeter_to_Surface_ratio emerged as the most significant predictor of UUTD (AUC = 0.722, 95% confidence interval [CI]: 0.674-0.769). The support vector machine (SVM) model demonstrated the highest performance, with an AUC of 0.860 (95% CI: 0.820-0.899) in the training cohort and 0.830 (95% CI: 0.744-0.915) in the test cohort, which was significantly higher than the performance of using single features. However, incorporating clinical information did not further enhance the overall predictive performance of the model. To realize a fully E2E approach, a fully convolutional network with a ResNet101 backbone (FCN-ResNet101) was adopted for automated bladder segmentation (dice similarity coefficient [Dice] = 0.9848, mean intersection over union [mIoU] = 0.9705). Morphology features extracted from automated and manual segmentations showed a strong correlation (all r > 0.90). Similarly, machine learning models were developed, with SVM achieving the highest performance (AUC = 0.843, 95% CI: 0.801-0.885 in the training cohort; AUC = 0.815, 95% CI: 0.729-0.900 in the testing cohort).

conclusionThe bladder morphology features are robust predictors of UUTD. This fully automated, E2E bladder segmentation and UUTD risk prediction model demonstrated superior performance compared to traditional clinical parameters, providing a quantitative and objective tool for early risk assessment. Large-scale, multicenter prospective studies are required to validate its clinical applicability and robustness in the future.

Indexed as

Urinary BladderUrinary Bladder, NeurogenicAdultAgedAlgorithmsFemaleHumansMachine LearningMaleMiddle AgedRetrospective StudiesRisk AssessmentSupport Vector MachineUrodynamicsautomated segmentationbladder morphology featuresneurogenic bladderrisk modelupper urinary tract dysfunction

Identifiers

PMID40932342
PMCPMC12825539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.